BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND ACVR2A, ACVR2, 92, ENSG00000121989, ACTRII, P27037 AND Diagnosis
774 results:

  • 1. Evaluation of childhood malignancies presenting with musculoskeletal manifestations from two different divisions: a multicenter study.
    Çağlayan Ş; Koç BŞ; Baba Ö; Bağlan E; Kurucu B; Yıldırım DG; Ayhan AC; Çakan M; Yener GO; Öztürk K; Çakmak F; Sönmez HE; Ayaz NA; Kısaarslan AP; Bakkaloğlu S; Kalyoncu M; Kılıç SÇ; Sözeri B
    Turk J Pediatr; 2024; 66(1):81-89. PubMed ID: 38523382
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Spotlight on the real-world treatment of CML pts in Germany: a retrospective survey in private oncology practices.
    Franke GN; Loewe G; Reiser M; Linde H; Josting A; von der Heyde E; Platzbecker U; Weide R; Tesch H; Nusch A; Dengler J; Jentsch-Ullrich K
    Ann Hematol; 2024 May; 103(5):1569-1575. PubMed ID: 38472361
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. COVID-19 in Pediatric Patients With Acute Lymphoblastic leukemia or Lymphoma.
    Hashmi SK; Bodea J; Patni T; Angel S; Bhakta NH; Jeha S; Karol SE; Ribeiro RC; Rubnitz JE; Wolf J; Li Y; Pui CH; Hijano DR; Inaba H
    JAMA Netw Open; 2024 Feb; 7(2):e2355727. PubMed ID: 38363571
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Incidence, risk factors, and outcomes of second neoplasms in patients with acute promyelocytic leukemia: the PETHEMA-PALG experience.
    Sobas M; Knopinska-Posluszny W; Piątkowska-Jakubas B; García-Álvarez F; Díez MEA; Caballero M; Martínez-Cuadrón D; Aguiar E; González-Campos J; Garrido A; Algarra L; Salamero O; de la Serna J; Sayas MJ; Perez-Encinas MM; Vives S; Vidriales B; Labrador J; Prado AI; Celebrin L; Mayer J; Brioso J; de Laiglesia A; Bergua JM; Amigo ML; Rodriguez-Medina C; Polo M; Pluta A; Cichocka E; Skarupski M; Sanz MA; Wierzbowska A; Montesinos P
    Ann Hematol; 2024 Feb; 103(2):451-461. PubMed ID: 38110588
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Label-free microfluidic chip for segregation and recovery of circulating leukemia cells: clinical applications in acute myeloid leukemia.
    Ouyang D; Ye N; Jiang Y; Wang Y; Hu L; Chao S; Yarmush M; Tuner M; Li Y; Tang B
    Biomed Microdevices; 2023 Dec; 26(1):3. PubMed ID: 38085348
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Detection of dysplasia in peripheral blood: Proposal of an algorithm to detect myelodysplastic syndromes and chronic myelomonocytic leukemias on a high-speed technical platform using the Sysmex XN™ analyser.
    Bouriche L; Fuster L; Laurent H; Soler C; Benhabib S
    Int J Lab Hematol; 2024 Apr; 46(2):286-293. PubMed ID: 38083991
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [Clinical Analysis of Infants with Acute Lymphoblastic leukemia (18 cases)].
    Li KL; Xiong H; Li H; Wang Z; Chen Z; Yang L; Lu WJ; Qi SS; Sun M
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Dec; 31(6):1670-1675. PubMed ID: 38071044
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Usefulness Of Sofosbuvir And Daclatasvir Combination In The Treatment Of HCV Infection In Childhood Cancer Patients: Experience From A Tertiary Care Hospital.
    Imam U; Parkash A; Daryani N; Mumtaz F
    J Pak Med Assoc; 2023 Nov; 73(11):2183-2188. PubMed ID: 38013525
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Frequency of TP53 Mutation in B-Cell Chronic Lymphocytic Leukaemia and its Association with Lymphocyte Doubling Time.
    Ali SM; Irfan SM; Raza N
    J Coll Physicians Surg Pak; 2023 Nov; 33(11):1249-1253. PubMed ID: 37926876
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Optical genome mapping for prenatal diagnosis: A prospective study.
    Goumy C; Guy Ouedraogo Z; Soler G; Eymard-Pierre E; Laurichesse H; Delabaere A; Gallot D; Bouchet P; Perthus I; Pebrel-Richard C; Gouas L; Salaun G; Salse J; Véronèse L; Tchirkov A
    Clin Chim Acta; 2023 Nov; 551():117594. PubMed ID: 37832906
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Characterization and diagnosis spectrum of patients with cerebrospinal fluid pleocytosis.
    Dyckhoff-Shen S; Bewersdorf JP; Teske NC; Völk S; Pfister HW; Koedel U; Klein M
    Infection; 2024 Feb; 52(1):219-229. PubMed ID: 37656347
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. [Analysis of
    Cui M; Li QY; Lu XZ; Chao HY; Cai XH; Liu J; Hua HY; Wu P
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Aug; 31(4):1019-1025. PubMed ID: 37551471
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Malignancy risk in patients with atopic dermatitis: a population-based cohort study.
    Wan J; Shin DB; Syed MN; Abuabara K; Lemeshow AR; Fuxench ZCC; Gelfand JM
    Br J Dermatol; 2023 Jul; 189(1):53-61. PubMed ID: 37418646
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. miR-155 and miR-92 levels in ALL, post-transplant aGVHD, and CMV: possible new treatment options.
    Saadi MI; Nikandish M; Ghahramani Z; Valandani FM; Ahmadyan M; Hosseini F; Rahimian Z; Jalali H; Tavasolian F; Abdolyousefi EN; Kheradmand N; Ramzi M
    J Egypt Natl Canc Inst; 2023 Jun; 35(1):18. PubMed ID: 37332027
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Maternal morbidity and mortality among patients with cancer at time of delivery.
    Sundermann AC; Cate JM; Campbell AK; Dotters-Katz SK; Myers ER; Federspiel JJ
    Am J Obstet Gynecol; 2023 Sep; 229(3):324.e1-324.e7. PubMed ID: 37295633
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Clinical metagenomic sequencing of plasma microbial cell-free DNA for febrile neutropenia in patients with acute leukaemia.
    Feng S; Rao G; Wei X; Fu R; Hou M; Song Y; Xu C; Han P; Gong B; Chen X; Wang Y; Dong X; Jiang Z; Wang J
    Clin Microbiol Infect; 2024 Jan; 30(1):107-113. PubMed ID: 37271194
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Non-T-depleted haploidentical transplantation with post-transplant cyclophosphamide in patients with secondary versus de novo AML in first complete remission: a study from the ALWP/EBMT.
    Nagler A; Labopin M; Blaise D; Raiola AM; Corral LL; Bramanti S; Sica S; Kwon M; Koc Y; Pavlu J; Kulagin A; Busca A; Rodríguez AB; Reményi P; Schmid C; Brissot E; Sanz J; Bazarbachi A; Giebel S; Ciceri F; Mohty M
    J Hematol Oncol; 2023 May; 16(1):58. PubMed ID: 37248463
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. First-line second generation tyrosine kinase inhibitors in patients with newly diagnosed accelerated phase chronic myeloid leukemia.
    Balsat M; Alcazer V; Etienne G; Huguet F; Berger M; Cayssials E; Charbonnier A; Escoffre-Barbe M; Johnson-Ansah H; Legros L; Roy L; Delmer A; Ianotto JC; Orvain C; Larosa F; Meunier M; Amé S; Andreoli A; Cony-Makhoul P; Morisset S; Tigaud I; Rea D; Nicolini FE
    Leuk Res; 2023 Jul; 130():107308. PubMed ID: 37230027
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Convalescent plasma for people with COVID-19: a living systematic review.
    Iannizzi C; Chai KL; Piechotta V; Valk SJ; Kimber C; Monsef I; Wood EM; Lamikanra AA; Roberts DJ; McQuilten Z; So-Osman C; Jindal A; Cryns N; Estcourt LJ; Kreuzberger N; Skoetz N
    Cochrane Database Syst Rev; 2023 May; 5(5):CD013600. PubMed ID: 37162745
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Quizartinib plus chemotherapy in newly diagnosed patients with FLT3-internal-tandem-duplication-positive acute myeloid leukaemia (QuANTUM-First): a randomised, double-blind, placebo-controlled, phase 3 trial.
    Erba HP; Montesinos P; Kim HJ; Patkowska E; Vrhovac R; Žák P; Wang PN; Mitov T; Hanyok J; Kamel YM; Rohrbach JEC; Liu L; Benzohra A; Lesegretain A; Cortes J; Perl AE; Sekeres MA; Dombret H; Amadori S; Wang J; Levis MJ; Schlenk RF;
    Lancet; 2023 May; 401(10388):1571-1583. PubMed ID: 37116523
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 39.